BioXcel Therapeutics (BTAI) Q2 2024 Earnings

May 9Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.83
-1.44
-1.06
-0.67

Details

Expected EPS
-0.67494
Actual EPS
-0.87
Surprise EPS
-0.2
Surprise Percent
-28.9%

Description

⁨BioXcel Therapeutics⁩ (⁦BTAI⁩) has reported earnings of ⁦-0.87⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts